Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Response
- PMID: 26275954
- PMCID: PMC4538982
- DOI: 10.1158/1078-0432.CCR-15-0931
Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Response
Conflict of interest statement
Comment on
-
Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.Clin Cancer Res. 2015 Jan 1;21(1):211-20. doi: 10.1158/1078-0432.CCR-14-1816. Epub 2014 Oct 27. Clin Cancer Res. 2015. PMID: 25348513 Free PMC article.
-
Effects of BRCA1/2 on Ovarian and Breast Cancer Survival--Letter.Clin Cancer Res. 2015 Aug 15;21(16):3806. doi: 10.1158/1078-0432.CCR-15-0418. Clin Cancer Res. 2015. PMID: 26275953 No abstract available.
References
-
- Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000;283:2260–2265. - PubMed
-
- Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine. 1998;17:2815–2834. - PubMed
-
- Deeks JJ, Higgins JPT. http://tech.cochrane.org/revman/documentation/Statistical-methods-in-Rev....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
